Gefitinib N-oxide 0786 Wogonin activates PPAR-γ expression in

Wogonin activates PPAR-γ expression in mice with ALD and EtOH induced RAW264

Oklinski MK

Discovery of a Novel Dual Histone Deacetylases (HDACs) and Mammalian Target of Rapamycin (mTOR) Target Inhibitor as a Promising Strategy for Cancer Therapy

Solubility: DMSO : 25 mg/mL (47

3-oxazol-5-yl)phenyl]carbamoyl}amino)phenyl]ethyl]carbamate

Gefitinib N-oxide 0786 Wogonin activates PPAR-γ expression inGefitinib N oxide is the N oxide derivative of Gefitinib. Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2 37 nM in NR6wtEGFR cells. Product information CAS Number: 847949 51 3 Molecular Weight: 462. 90 Formula: C22H24ClFN4O4 Chemical Name: 4 [3 ({4 [(3 chloro 4 fluorophenyl)amino] 7 methoxyquinazolin 6 yl}oxy)propyl]morpholin 4 ium 4 olate Smiles: COC1=CC2=NC=NC(NC3=CC(Cl)=C(F)C=C3)=C2C=C1OCCC[N+]1([O ])CCOCC1 InChiKey: FIKOGZWCACSBHA